Novavax, Inc. (NVAX)
10.80
-0.46
(-4.04%)
USD |
NASDAQ |
Oct 19, 16:00
10.83
+0.02
(+0.23%)
After-Hours: 17:21
Novavax Cash from Operations (Annual) : -244.64M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -244.64M |
| December 31, 2024 | -87.26M |
| December 31, 2023 | -717.56M |
| December 31, 2022 | -415.94M |
| December 31, 2021 | 322.95M |
| December 31, 2020 | -42.54M |
| December 31, 2019 | -136.62M |
| December 31, 2018 | -184.82M |
| December 31, 2017 | -136.62M |
| December 31, 2016 | -258.77M |
| December 31, 2015 | -89.89M |
| December 31, 2014 | -68.13M |
| December 31, 2013 | -44.93M |
| December 31, 2012 | -18.23M |
| December 31, 2011 | -23.63M |
| December 31, 2010 | -32.85M |
| Date | Value |
|---|---|
| December 31, 2009 | -32.83M |
| December 31, 2008 | -24.31M |
| December 31, 2007 | -26.74M |
| December 31, 2006 | -14.81M |
| December 31, 2005 | -5.809M |
| December 31, 2004 | -30.10M |
| December 31, 2003 | -17.55M |
| December 31, 2002 | -21.07M |
| December 31, 2001 | -4.566M |
| December 31, 2000 | -10.04M |
| December 31, 1999 | -3.70M |
| December 31, 1998 | -3.624M |
| December 31, 1997 | -4.245M |
| December 31, 1996 | -3.651M |
| December 31, 1995 | -6.261M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Moderna, Inc. | -1.873B |
| Merck & Co., Inc. | 16.47B |
| Pfizer Inc. | 11.70B |
| Amgen, Inc. | 9.958B |
| Editas Medicine, Inc. | -165.24M |